SCHEMBL32669063

SCHEMBL32669063

OCc1cnc(-c2ccc(C3CCOCC3)cc2)o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.39
USP7 Q93009 1/20 0.38
NOTUM Q6P988 4/20 0.38
PRKAB2 O43741 3/20 0.37
PRKAG1 P54619 3/20 0.37
PRKAA2 P54646 3/20 0.37
PRKAA1 Q13131 3/20 0.37
PRKAG3 Q9UGI9 3/20 0.37
PRKAG2 Q9UGJ0 3/20 0.37
PRKAB1 Q9Y478 3/20 0.37
AXL P30530 1/20 0.36
FLT3 P36888 1/20 0.36
TYRO3 Q06418 1/20 0.36
MERTK Q12866 1/20 0.36
HDAC3 O15379 4/20 0.36
HDAC1 Q13547 4/20 0.36
HDAC2 Q92769 4/20 0.36
HDAC8 Q9BY41 4/20 0.36
HDAC6 Q9UBN7 4/20 0.36
HDAC4 P56524 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669106 0.76 NOTUM (0.54) MAPK1NOTUMPRKAB2PRKAG1PRKAA2
SCHEMBL32669136 0.75 NOTUM (0.56) MAPK1NOTUMPRKAB2PRKAG1PRKAA2
SCHEMBL32669116 0.75 NOTUM (0.40) MAPK1USP7NOTUMPRKAB2PRKAG1
SCHEMBL32669070 0.73 KDM4E (0.40) MAPK1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL9832665 0.72 ALDH1A1 (0.53) NOTUMHDAC3HDAC1HDAC2HDAC8
SCHEMBL24784588 0.72 HDAC1 (0.55) NOTUMHDAC3HDAC1HDAC2HDAC8
SCHEMBL12733063 0.70 KCNH2 (0.41) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL29515354 0.70 PRMT5 (0.41) MAPK1KCNH2HRH3PIK3CBPRKDC
SCHEMBL24323890 0.70 PRMT5 (0.41) MAPK1KCNH2HRH3PIK3CBPRKDC
SCHEMBL32669128 0.68 ALDH1A1 (0.54) NOTUMAXLFLT3MERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035358-A1 WEE1 DEGRADING COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035358-A1 WEE1 DEGRADING COMPOUNDS AND USES THEREOF CRBN, WEE1, WEE2 MAPK1 1077/4885USP7 298/4885NOTUM 1387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.